Similar articles

• [Antiganglioside antibodies: when, which and for what].

  Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I. Gallardo E, et al. Neurologia. 2001 Aug-Sep;16(7):293-7. Neurologia. 2001. PMID: 11485721 Spanish.
• Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?

  Dalakas MC, Quarles RH. Dalakas MC, et al. Ann Neurol. 1996 Apr;39(4):419-22. doi: 10.1002/ana.410390402. Ann Neurol. 1996. PMID: 8619518 No abstract available.
• Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy.

  Caudie C. Caudie C. Clin Rev Allergy Immunol. 2000 Aug;19(1):7-18. doi: 10.1385/CRIAI:19:1:7. Clin Rev Allergy Immunol. 2000. PMID: 11064822 Review. No abstract available.
• Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.

  Lim JP, Devaux J, Yuki N. Lim JP, et al. Autoimmun Rev. 2014 Oct;13(10):1070-8. doi: 10.1016/j.autrev.2014.08.005. Epub 2014 Aug 27. Autoimmun Rev. 2014. PMID: 25172243 Review.
• A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies.

  Conrad K, Schneider H, Ziemssen T, Talaska T, Reinhold D, Humbel RL, Roggenbuck D. Conrad K, et al. Ann N Y Acad Sci. 2007 Aug;1109:256-64. doi: 10.1196/annals.1398.031. Ann N Y Acad Sci. 2007. PMID: 17785314